title: [Withdrawing of IVIG compound from the market].
authors.affiliation: shoenfel@post.tau.ac.il
authors.forename: Y
authors.initials: Y
authors.lastname: Shoenfeld
mesh_terms: D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D007557:Israel; D057051:Product Recalls and Withdrawals
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors